-
Medicare patients eligible to receive reimbursement for Dexcom system
SAN DIEGO — The Dept. of Health and Human Services’ Centers for Medicaid and Medicare Services published an article clarifying that Medicare beneficiaries who previously struggled to control their diabetes will now be able to obtain reimbursement for the Dexcom G5 Mobile System.
According to Dexcom, its continuous glucose monitoring system (CGM) is proven to significantly lower A1C levels resulting in lowered medical costs from diabetes complications (e.g., ER visits, seizures, etc.) and is now the only device approved for CGM for Medicare.